内部人交易记录
其他尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Krishnamohan Neha. Insider active across 3 companies, notably Kinnate Biopharma Inc.. In total, 17 reports have been published. History available since 1 September 2022. The latest transaction was disclosed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Krishnamohan Neha
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报17 总计
5,778 股0Common StockSEC:0001628280-26-042039:0
27,052 股@ US$8.63100.0% 占其流量Common StockSEC:0001866171-25-000007:0
3,490 股@ US$3.2579.3% 占其流量Common StockSEC:0001193125-25-285005:0
1,341 股@ US$2.13100.0% 占其流量Common StockSEC:0001415889-25-022222:0
7,609 股0Common StockSEC:0002065881-25-000024:0
60,000 股0Common StockSEC:0001415889-25-006034:0
50,000 股0Common StockSEC:0001415889-24-023361:0
10,139 股0Common StockSEC:0001787306-24-000102:0
64,087 股Common StockSEC:0001415889-24-010431:0
1,506 股@ US$2.5910.3% 占其流量Common StockSEC:0001415889-24-006755:0
1,459 股@ US$2.258.6% 占其流量Common StockSEC:0001209191-23-057455:0
1,459 股@ US$2.359.0% 占其流量Common StockSEC:0001209191-23-048429:0
1,459 股@ US$4.3016.7% 占其流量Common StockSEC:0001209191-23-034447:0
4,375 股0Common StockSEC:0001787306-23-000052:0
1,721 股@ US$5.2124.3% 占其流量Common StockSEC:0001209191-23-015868:0
1,459 股@ US$7.7531.0% 占其流量Common StockSEC:0001209191-22-059514:0
67,500 股0Common StockSEC:0001209191-22-048526:0
About Krishnamohan Neha
Krishnamohan Neha has filed 17 disclosures in total. In the recent disclosures held, they span the period from 2022-09-02 to 2026-06-09, with 0 in buys and 0 in sells, and the most common transaction nature is Retenue fiscale. They are associated with Kinnate Biopharma Inc. as CHIEF FINANCIAL OFFICER, with Arcutis Biotherapeutics, Inc. as Director, and with Artiva Biotherapeutics, Inc. as Chief Financial Officer.